HBCo — Hofseth Biocare ASA Balance Sheet
0.000.00%
- NOK614.57m
- NOK847.60m
- NOK256.34m
Annual balance sheet for Hofseth Biocare ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 47.2 | 29.9 | 20.9 | 22.6 | 67 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 10.1 | 14.1 | 14.8 | 18.9 | 21.5 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 170 | 176 | 131 | 112 | 162 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 186 | 169 | 166 | 138 | 147 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 416 | 411 | 390 | 339 | 394 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 151 | 172 | 252 | 168 | 241 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 275 | 262 | 348 | 279 | 469 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 141 | 149 | 41.8 | 60 | -74.8 |
| Total Liabilities & Shareholders' Equity | 416 | 411 | 390 | 339 | 394 |
| Total Common Shares Outstanding |